Emetrol

What Emetrol does

Emetrol is an over-the-counter pharmaceutical brand specializing in nausea and upset stomach relief, originally developed in 1949 and held under trademark since 1951. The product family comprises three SKUs: Emetrol Liquid (the legacy formulation for nausea and upset stomach, approved for children ages 2 and up), Emetrol Chewables (chewable tablets formulated for adults with nausea from overindulgence in food and drink), and Emetrol Powder (a portable on-the-go format). The core technology is a pharmaceutical formulation that claims to calm stomach muscle contractions rather than simply coating the stomach lining, and is positioned as free from alcohol, caffeine, antihistamines, and aspirin.

Emetrol is a brand owned and operated by WellSpring Pharmaceutical Corporation, a privately held diversified consumer healthcare company headquartered in Sarasota, Florida, that also owns A+D, Bactine, Bonine, Gelusil, Solarcaine, Recticare, Dermend, and vH essentials. The business makes money through one-time-purchase OTC product sales via a channel-partner go-to-market: its products are listed in major national pharmacy chains (Walgreens, Rite Aid, CVS, Kinney Drugs), grocery chains (Publix, Wegmans, HEB, Giant Eagle, Harris Teeter, Meijer), mass merchants (Walmart, Harmon), and e-commerce platforms (Amazon). All operations are confined to the United States.

Marketing emphasis centers on long-standing brand trust (over 60 years), pharmacist recommendation (the brand was named #1 pharmacist-recommended nausea remedy by U.S. News & World Report and Pharmacy Times for 2012-2013), and NIH recognition as a staple home remedy. Customer segments are horizontal, targeting both families with young children and adults. The company has 11-50 employees (reported at the parent level) and is private, with no public ticker, funding rounds, or M&A activity disclosed.

Name

Emetrol

Legal name

WellSpring Pharmaceutical Corporation

Website

https://emetrol.com

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

11–50 employees

Short description

Emetrol is a U.S. over-the-counter pharmaceutical brand that sells liquid, chewable, and powder nausea-relief medications through national pharmacy, grocery, mass, and online retailers, serving families and adults under owner WellSpring Pharmaceutical Corporation.

Ownership category

akta.pro rank

Product category

Over-the-counter antiemetic pharmaceuticals

akta.pro primary industry

Gastrointestinal & Digestive Health (HLAIADAD)

akta.pro secondary industry

Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)

Keywords

• Over-the-counter nausea medication
• Upset stomach relief
• OTC digestive health
• Antiemetic chewables
• Consumer pharmaceutical products

Headquarters

HQ city

Sarasota

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Others

Revenue model

1. OTC Pharmaceutical Product Sales: Emetrol generates revenue through the sale of its OTC nausea medications (liquid and chewable forms) distributed through retail pharmacy and grocery chains as well as online marketplaces.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Emetrol manufactures and sells over-the-counter nausea and upset stomach medications in three formats: a liquid formulation safe for children ages 2 and up, chewable tablets formulated for adults, and a portable powder form for on-the-go use. The products' branded mechanism is the calming of stomach muscle contractions that can lead to vomiting, and all formulations are free from alcohol, caffeine, antihistamines, and aspirin.

Product overview

Emetrol is a family of over-the-counter nausea medications consisting of three product forms: Emetrol Liquid (for nausea and upset stomach, safe for children 2 and up), Emetrol Chewables (chewable tablets for adults for nausea due to overindulgence in food and drink), and Emetrol Powder (portable powder form). All products treat the source of nausea by calming stomach muscle contractions, rather than simply coating the stomach. The brand has been trusted for over 60 years and is free from alcohol, caffeine, antihistamines, and aspirin.

Differentiator

Problem solved

Functional benefit

Brands

• Emetrol Liquid: Over-the-counter medication for relieving nausea associated with upset stomach. Safe for children ages 2 and up. Treats the source of nausea by calming stomach muscle contractions.
• Emetrol Chewables
• Emetrol Powder

Products and services

• Emetrol Liquid Over-the-counter liquid medication for relieving nausea associated with upset stomach. Works by calming stomach muscle contractions that can lead to vomiting. Safe for children ages 2 and up. Free from alcohol, caffeine, antihistamines, and aspirin.
• Emetrol Chewables Over-the-counter chewable tablets for nausea in adults associated with overindulgence in food and drink. Free from alcohol, caffeine, antihistamines, and aspirin.
• Emetrol Powder Portable powder form of Emetrol nausea medication designed for on-the-go use, allowing consumers to take Emetrol outside the home.

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Nauzene: Nauzene (WellSpring Pharmaceutical-owned sister brand) is the closest direct peer — same parent, same category, same retail buyers, but a chewable formulation. Useful for benchmarking intra-category cannibalization and parent-company portfolio dynamics.
• Gelusil: Gelusil (WellSpring-owned) is another sister brand in the digestive health OTC space, offering an antacid alternative that competes with Emetrol for upset-stomach consumers at the same retailers.
• Dramamine: Dramamine (Prestige Consumer Healthcare) is a direct competitor in the OTC nausea space, with overlapping retail pharmacy distribution and a comparable lay/educator-led marketing model. Both target motion sickness and general nausea consumers.
• Bonine: Bonine (also WellSpring-owned) targets motion-sickness nausea, making it a sister-brand competitor in the same nausea-relief category. Useful for understanding brand-portfolio cannibalization and motion-sickness market positioning.

Broad incumbents

• Haleon: Haleon is a broad consumer healthcare incumbent whose digestive health portfolio (Tums, etc.) competes for the same shelf set. Useful as a public-market comp for OTC digestive category economics.
• Tums (Haleon): Tums (Haleon) is a broad OTC digestive remedy with dominant distribution, often co-located with Emetrol on store shelves. While not a direct nausea-indication match, it competes for the same consumer wallet and shelf space.
• Pepto-Bismol: Pepto-Bismol (P&G) is the category-leading OTC nausea/upset stomach remedy with similar distribution into Walmart, CVS, Walgreens and Amazon. It competes for the same shelf and consumer occasions as Emetrol but at much greater scale and brand spend.
• Emetrol (Prestige Consumer Healthcare private label): Prestige Consumer Healthcare is a relevant incumbent comparable — public OTC roll-up of similar digestive/motion brands with competing private-label and branded SKUs at the same retailers.
• Kaopectate: Kaopectate (CHPA-OTC category staple) targets gastrointestinal upsets through major mass retailers, overlapping with Emetrol's distribution and consumer occasions.

Others

• WellSpring Pharmaceutical Corporation: WellSpring is the actual parent company of Emetrol; included as a peer for vertical-context understanding of the brand-owner's portfolio composition and capital allocation choices.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Emetrol
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emetrol